COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018 – Conference Call to Follow

08/03/2018 - 22:45

ALPHARETTA, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]

Cara Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018

08/03/2018 - 22:30

STAMFORD, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results

08/03/2018 - 22:25

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced its fourth quarter and year-end 2017 financial results and provided updates on its corporate [...]

Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

08/03/2018 - 22:24

Type C meeting completed with FDA for OTIVIDEX™ in Ménière’s disease Consistent with prior guidance, pivotal trial for OTIVIDEX to start mid-2018 Conference call and webcast today at 4:30 p.m. EST SAN DIEGO, March 08, [...]

The Cooper Companies Announces First Quarter 2018 Results

08/03/2018 - 22:17

PLEASANTON, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced financial results for the fiscal first quarter ended January 31, 2018. First quarter revenue increased 18% [...]

OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

08/03/2018 - 22:15

Navicixizumab and anti-TIGIT data expected in the 2 nd Half of 2018 Management to Host Conference Call/Webcast this afternoon at 4:30 p.m. ET / 1:30 p.m. PT REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- [...]

Alpha Pro Tech, LTD. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2017

08/03/2018 - 22:15

Net income for 2017 was $2.6 million, or $0.18 per diluted share, compared to $3.2 million, or $0.19 per diluted share, for 2016 Excluding a $619,000 accrual related to the death of our former President and Chairman, [...]

Albert White to Succeed Robert Weiss as CEO of the Cooper Companies

08/03/2018 - 22:15

PLEASANTON, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that its Board of Directors has named Albert G. White III President and Chief Executive Officer of The [...]

INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results

08/03/2018 - 22:15

PHOENIX, March 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reported [...]

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:15

- On track to begin first company-sponsored clinical trials of a CRISPR-based therapy - - Wholly-owned CRISPR-based allogeneic CAR-T programs advancing rapidly - ZUG, Switzerland and CAMBRIDGE, Mass., March 08, 2018 ( [...]

Clearside Biomedical to Present at the Cowen and Company 38th Annual Health Care Conference

08/03/2018 - 22:15

ALPHARETTA, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]

Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights

08/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs [...]

The Joint Corp. Reports Fourth Quarter and Full Year 2017 Financial Results

08/03/2018 - 22:05

29% Annual System-Wide Gross Sales Increase to $126.9 Million for 2017 23% Annual Revenue Growth to $25.2 Million for 2017 $11.9 Million Improvement in Net Loss to $(3.3) Million for 2017 $7.6 Million, or 99%, [...]

Codexis Reports 2017 Fourth Quarter and Full Year Financial Results

08/03/2018 - 22:05

2017 revenues of $50 million include a 74% increase in product sales Introduces 2018 financial guidance Conference call begins at 4:30 pm Eastern time today Accompanying slide presentation available on Investor section [...]

MediWound to Present at Two Investor Conferences

08/03/2018 - 22:05

YAVNE, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

IRIDEX Announces 2017 Fourth Quarter and Full Year Financial Results

08/03/2018 - 22:05

MOUNTAIN VIEW, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and full year ended December 30, 2017. Fourth Quarter Highlights Fourth [...]

Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2017 Financial Results

08/03/2018 - 22:05

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will report financial results for the three months ended December 31, 2018, before the opening of trading [...]

Caladrius Biosciences to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

08/03/2018 - 22:05

BASKING RIDGE, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08/03/2018 - 22:05

MENLO PARK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]